Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: Findings from a family study

Neurobiology of Aging

Volumn 35, Issue 3, 2014, Pages 725.e7-725.e10

  Van Exel, E ^a   Eikelenboom, P ^a,b   Comijs, H ^a   Deeg, D J H ^a   Stek, M L ^a   Westendorp, R G J ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Family study; Insulin like growth factor 1

Indexed keywords

APOLIPOPROTEIN E; SOMATOMEDIN C;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DEMOGRAPHY; FAMILY; FAMILY HISTORY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONSET AGE; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; VERY ELDERLY;

ALZHEIMER'S DISEASE; FAMILY STUDY; INSULIN-LIKE GROWTH FACTOR-1;

AGE OF ONSET; ALZHEIMER DISEASE; ANIMALS; APOLIPOPROTEINS E; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MIDDLE AGED; RISK; SIGNAL TRANSDUCTION;

EID: 84889583155     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.08.014     Document Type: Article

References (10)

1. Birketvedt G.S., Geliebter A., Kristiansen I., Firgenschau Y., Goll R., Florholmen J.R. Diurnal secretion of ghrelin, growth hormone, insulin binding proteins, and prolactin in normal weight and overweight subjects with and without the night eating syndrome. Appetite 2012, 59:688-692.
2. Cohen E., Paulsson J.F., Blinder P., Burstyn-Cohen T., Du D., Estepa G., Adame A., Pham H.M., Holzenberger M., Kelly J.W., Masliah E., Dillin A. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009, 139:1157-1169.
3. Dik M.G., Pluijm S.M., Jonker C., Deeg D.J., Lomecky M.Z., Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol. Aging 2003, 24:573-581.
4. Euser S.M., van Heemst D., van Vliet P., Breteler M.M.B., Westendorp R.G. Insulin/insulin-like growth factor-1 signaling and cognitive function in humans. J.Gerontol 2008, 9:907-910.
5. Fontana L., Partridge L., Longo V.D. Extending healthy life span-from yeast to humans. Science 2010, 328:321-326.
6. Garinis G.A., van der Horst G.T., Vijg J., Hoeijmakers J.H. DNA damage and ageing: new-age ideas for an age-old problem. Nature Cell Biol 2008, 10:1241-1247.
7. Kalmijn S., Janssen J.A.M.J.L., Pols H.A.P., Lamberts S.W.J., Breteler M.M.B. Aprospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J.Clin. Endocrinol. Metab 2000, 85:4551-4555.
8. Kuningas M., Mooijaart S.P., van Heemst D., Zwaan B.J., Slagboom P.E., Westendorp R.G. Genes encoding longevity: from model organisms to humans. Aging Cell 2008, 7:270-280.
9. Taekema D.G., Carolina H., Ling Y., Blauw G.J., Meskers C.J., Westendorp R.G.J., de Craen A.J.M., Maier A.B. Circulating levels of insulin-like growth factor-1 are associated with muscle strength in middle aged and oldest old women. Eur. J. Endocrinol 2011, 164:189-196.
10. van Vliet P., Westendorp R.G.J., Eikelenboom P., Comijs H., Frölich M., Smit J.H., Stek M.L., Schelten P., Eefsting J.E., van Exel E. Parental history of Alzheimer's disease associates with lower plasma apolipoprotein E levels. Neurology 2009, 73:681-687.